Summary
32 / 100 · Bulios Score
What speaks for it
- The share price is below the Bulios Fair Price.
What to watch
- The company made a loss over the last 12 months.
- Revenue growth is slowing: 7.8% a year over the last 3 years against 38% over 5 years.
- It missed profit estimates 6 times in the last 8 quarters.
- It passes only 2 of the 9 points of the Piotroski financial health test.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks cheapBulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
The company made a loss over the last 12 months, so there is no profit to set the price against.
Valuation in detailIs it growing?
SlowlyRevenue (USD)
Diluted EPS (USD)
- Analyst estimate
Revenue grew by 38% a year over 5 years. Over the last 3 years it grew by 7.8% a year.
Growth in detailDoes it make money?
PoorlyOver the last 12 months it made a loss of $1.97B.
Profitability in detailIs it financially healthy?
Its debt is larger than its cash.
Financial health in detailDoes it pay a dividend?
NoIt pays no dividend.
Dividends in detailWhat do analysts expect?
Mildly negative- Buy 0
- Hold 2
- Sell 3
Today's price within the analysts' price targets
The average target of $126 is 3,333% above today's price. 0.0% of the analysts recommend buying.
Analysts in detailWhat does it earn on?
Fiscal year 2025By product
- Licenses And Royalties 86%
- Other Revenue 14%
By region
- UNITED KINGDOM 26%
- SWEDEN 21%
- GERMANY 7.5%
- NORWAY 6.4%
- UNITED STATES 5.7%
- Other 34%
Licenses And Royalties brings in 86% of revenue.
Segments in detail